Transaction · 0001817217-26-000014

Van Houte Hans

van Houte Hans, CFO, reported an open-market or private sale at Nurix Therapeutics, Inc. involving 2834.000000 shares for an estimated $74474.97. Reported holdings after the transaction were 47514.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCFO
NRIXNurix Therapeutics, Inc.
Trade date
Oct 30, 2026
Filing date
Nov 03, 2026
View on SEC Insider profile
Disclosed value-$74.4kShares × reported price
Shares traded2.83k$26.28 per share
Holdings after47.5kDirect
% of reported position traded5.63%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 50,348 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

NRIX price since this filing

Daily closing prices, with the filing date and available return windows
NRIX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -7.7%1w ago -1.4%1d ago +5.5%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001817217-26-000014
Common Stock
Transaction date
Oct 30, 2026
Filed Nov 03, 2026, 12:47 AM · 4d delay
Shares
2,834 sh
$26.28 per share
Estimated value
-$74.4k
Computed from shares × price
Holdings after
47,514 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). T…

  2. F2

    Represents the weighted average sale price. The lowest price at which shares were sold was $26.135 and the highest price at which shares were sold was $26.42. The Reporting Person undertakes to provid…

  3. F3

    Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

  4. F4

    The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2024, subject to the Reporting Person's provision of services to the…

  5. F5

    RSUs do not expire; they either vest or are canceled prior to the vest date.

  6. F6

    The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2025, subject to the Reporting Person's provision of services to the…

  7. F7

    The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the…

Original filing · 0001817217-26-000014
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NRIX